Universitätsklinikum des Saarlandes und Medizinische Fakultät der Universität des Saarlandes
Innere Medizin III - Kardiologie, Angiologie und internistische Intensivmedizin
Leitung: Prof. Dr. Michael Böhm
Sie befinden sich hier: >> Startseite >> Klinische Zentren und Einrichtungen >> Klinische Zentren und Einrichtungen am UKS >> Medizinische Kliniken >> Innere Medizin III >> Patienteninfo >> Bluthochdruck >> Wissenschaftliche Veröffentlichungen

Wissenschaftliche Veröffentlichungen

Jahrgang 2017
  1. Böhm M, Ewen S, Mahfoud F. Renal denervation for chronic heart failure: Background and pathophysiological rationale. Korean Circ J. 2017;47:9-15
  2. Böhm M, Laufs U, Mahfoud F, Schirmer SH, Kindermann I. Primum non nocere: The dangers of deferring heart failure therapy. Eur J Heart Fail. 2017
  3. Ewen S, Böhm M, Mahfoud F. Long-term follow-up of baroreflex activation therapy in resistant hypertension: Another piece of the puzzle? Hypertension. 2017;69:782-784
  4. Kindermann I, Wedegartner SM, Mahfoud F, Weil J, Brilakis N, Ukena J, Ewen S, Linz D, Fahy M, Mancia G, Böhm M. Improvement in health-related quality of life after renal sympathetic denervation in real-world hypertensive patients: 12-month outcomes in the global symplicity registry. J Clin Hypertens. 2017 (published online)
  5. Kulenthiran S, Ewen S, Böhm M, Mahfoud F. Hypertension up to date: Sprint to spyral. Clin Res Cardiol. 2017;106:475-484
  6. Linz D, Mancia G, Mahfoud F, Narkiewicz K, Ruilope L, Schlaich M, Kindermann I, Schmieder RE, Ewen S, Williams B, Böhm M. Renal artery denervation for treatment of patients with self-reported obstructive sleep apnea and resistant hypertension: Results from the global symplicity registry. J Hypertens. 2017;35:148-153
  7. Mahfoud F, Bakris G, Bhatt DL, Esler M, Ewen S, Fahy M, Kandzari D, Kario K, Mancia G, Weber M, Böhm M. Reduced blood pressure-lowering effect of catheter-based renal denervation in patients with isolated systolic hypertension: Data from symplicity htn-3 and the global symplicity registry. Eur Heart J. 2017;38:93-100
  8. Mahfoud F, Edelman ER. Renal denervation for treatment of hypertension - will 2017 be the year of enlightenment? EuroIntervention. 2017;12:e2163-e2165
  9. Mahfoud F, Pipenhagen CA, Boyce Moon L, Ewen S, Kulenthiran S, Fish JM, Jensen JA, Virmani R, Joner M, Yahagi K, Tsioufis C, Böhm M. Comparison of branch and distally focused main renal artery denervation using two different radio-frequency systems in a porcine model. Int J Cardiol. 2017;241:373-378
  10. Mahfoud F, Schmieder RE, Azizi M, Pathak A, Sievert H, Tsioufis C, Zeller T, Bertog S, Blankestijn PJ, Böhm M, Burnier M, Chatellier G, Durand Zaleski I, Ewen S, Grassi G, Joner M, Kjeldsen SE, Lobo MD, Lotan C, Felix Luscher T, Parati G, Rossignol P, Ruilope L, Sharif F, van Leeuwen E, Volpe M, Windecker S, Witkowski A, Wijns W. Proceedings from the 2nd european clinical consensus conference for device-based therapies for hypertension: State of the art and considerations for the future. Eur Heart J. 2017 (published online)
  11. Ott C, Lobo MD, Sobotka PA, Mahfoud F, Stanton A, Cockcroft J, Sulke N, Dolan E, van der Giet M, Hoyer J, Furniss SS, Foran JP, Witkowski A, Januszewicz A, Schoors D, Tsioufis K, Rensing BJ, Saxena M, Scott B, Ng GA, Achenbach S, Schmieder RE. Effect of arteriovenous anastomosis on blood pressure reduction in patients with isolated systolic hypertension compared with combined hypertension. J Am Heart Assoc. 2016;5
  12. Schirmer SH, Mahfoud F, Fries P, Scheller B. Thrombosis of tavi prosthesis-cause for concern or innocent bystander? A comment and review of currently available data. Clin Res Cardiol. 2017;106:79-84
  13. Selejan SR, Hewera L, Hohl M, Kazakov A, Ewen S, Kindermann I, Böhm M, Link A. Suppressed mmp-9 activity in myocardial infarction-related cardiogenic shock implies diminished rage degradation. Shock. 2017;48:18-28
  14. Tsioufis C, Dimitriadis K, Kordalis A, Doumas M, Konstantinidis D, Kalos T, Mahfoud F, Papademetriou V, Tousoulis D. Renal denervation therapy: Can it contribute to better blood pressure control in hypertension? Curr Vasc Pharmacol. 2017 (published online)
  15. Vogiatzakis N, Tsioufis C, Georgiopoulos G, Thomopoulos C, Dimitriadis K, Kasiakogias A, Konstantinidis D, Kalos T, Mahfoud F, Doumas M, Papademetriou V, Tousoulis D. Effect of renal sympathetic denervation on short-term blood pressure variability in resistant hypertension: A meta-analysis. J Hypertens. 2017;35:1750-1757
  16. Böhm M, Schumacher H, Teo KK, Lonn EM, Mahfoud F, Mann JFE, Mancia G, Redon J, Schmieder RE, Sliwa K, Weber MA, Williams B, Yusuf S. Achieved blood pressure and cardiovascular outcomes in high-risk patients: Results from ONTARGET and TRANSCEND trials. Lancet. 2017;389:2226-2237
Jahrgang 2016
  1. Ukena C, Mahfoud F, Ewen S, Bollmann A, Hindricks G, Hoffmann BA, Linz D, Musat D, Pavlicek V, Scholz E, Thomas D, Willems S, Böhm M, Steinberg JS. Renal denervation for treatment of ventricular arrhythmias: data from an International Multicenter Registry.
    Clin Res Cardiol 2016;105(10):873-9.
  2. Ott C, Mahfoud F, Schmid A, Ewen S, Toennes SW, Meyer MR, Helfer AG, Maurer HH, Ditting T, Veelken R, Zivanovic I, Uder M, Böhm M, Schmieder RE. The effect of renal denervation in moderate treatment-resistant hypertension with confirmed medication adherence.
    J Hypertens 2016;34(12):2475-2479.
  3. Ng FL, Saxena M, Mahfoud F, Pathak A, Lobo MD. Device-based Therapy for Hypertension. Curr Hypertens Rep 2016;18(8):61.
  4. Neumann JT, Ewen S, Mortensen K, Nef H, Zeller T, Ojeda F, Sydow K, Mahfoud F, Böhm M, Hamm C, Dorr O, Blankenberg S. Effects of renal denervation on heart failure biomarkers and blood pressure in patients with resistant hypertension.
    Biomark Med 2016;10(8):841-51.
  5. Mahfoud F, Moon LB, Pipenhagen CA, Jensen JA, Pathak A, Papademetriou V, Ewen S, Linz D, Böhm M. Catheter-based radio-frequency renal nerve denervation lowers blood pressure in obese hypertensive swine model.
    J Hypertens 2016;34(9):1854-62.
  6. Mahfoud F, Ewen S, Böhm M. Renal denervation in patients with heart failure with preserved ejection fraction: end of the beginning?
    Eur J Heart Fail 2016;18(6):713-5.
  7. Mahfoud F, Bakris G, Bhatt DL, Esler M, Ewen S, Fahy M, Kandzari D, Kario K, Mancia G, Weber M, Böhm M. Reduced blood pressure-lowering effect of catheter-based renal denervation in patients with isolated systolic hypertension: data from SYMPLICITY HTN-3 and the Global SYMPLICITY Registry.
    Eur Heart J 2016.
  8. Linz D, Hohl M, Vollmar J, Ukena C, Mahfoud F, Böhm M. Atrial fibrillation and gastroesophageal reflux disease: the cardiogastric interaction.
    Europace 2016.
  9. Linz D, Hohl M, Khoshkish S, Mahfoud F, Ukena C, Neuberger HR, Wirth K, Böhm M. Low-Level But Not High-Level Baroreceptor Stimulation Inhibits Atrial Fibrillation in a Pig Model of Sleep Apnea.
    J Cardiovasc Electrophysiol 2016;27(9):1086-92.
  10. Linz D, Denner A, Illing S, Hohl M, Ukena C, Mahfoud F, Ewen S, Reil JC, Wirth K, Böhm M. Impact of obstructive and central apneas on ventricular repolarisation: lessons learned from studies in man and pigs.
    Clin Res Cardiol 2016;105(8):639-47.
  11. Kandzari DE, Kario K, Mahfoud F, Cohen SA, Pilcher G, Pocock S, Townsend R, Weber MA, Böhm M. The SPYRAL HTN Global Clinical Trial Program: Rationale and design for studies of renal denervation in the absence (SPYRAL HTN OFF-MED) and presence (SPYRAL HTN ON-MED) of antihypertensive medications.
    Am Heart J 2016;171(1):82-91.
  12. Hohl M, Linz D, Fries P, Muller A, Stroeder J, Urban D, Speer T, Geisel J, Hummel B, Laufs U, Schirmer SH, Böhm M, Mahfoud F. Modulation of the sympathetic nervous system by renal denervation prevents reduction of aortic distensibility in atherosclerosis prone ApoE-deficient rats.
    J Transl Med 2016;14(1):167.
  13. Gitt AK, Bramlage P, Potthoff SA, Baumgart P, Mahfoud F, Buhck H, Ehmen M, Ouarrak T, Senges J, Schmieder RE. Azilsartan compared to ACE inhibitors in anti-hypertensive therapy: one-year outcomes of the observational EARLY registry.
    BMC Cardiovasc Disord 2016;16:56.
  14. Ewen S, Zivanovic I, Mahfoud F. Renal Denervation Induces Reverse-Remodeling in MicroRNA: Just Blood Pressure Reduction or More?
    J Clin Hypertens (Greenwich) 2016;18(6):495-6.
  15. Ewen S, Zivanovic I, Böhm M, Mahfoud F. CardioPulse. Catheter-based renal denervation for hypertension treatment: update 2015.
    Eur Heart J 2016;37(12):930-3.
  16. Ewen S, Ukena C, Luscher TF, Bergmann M, Blankestijn PJ, Blessing E, Cremers B, Dorr O, Hering D, Kaiser L, Nef H, Noory E, Schlaich M, Sharif F, Sudano I, Vogel B, Voskuil M, Zeller T, Tzafriri AR, Edelman ER, Lauder L, Scheller B, Böhm M, Mahfoud F. Anatomical and procedural determinants of catheter-based renal denervation.
    Cardiovasc Revasc Med 2016;17(7):474-479.
  17. Ewen S, Nikolovska A, Zivanovic I, Kindermann I, Böhm M. [Chronic heart failure - new insights].
    Dtsch Med Wochenschr 2016;141(21):1560-1564.
  18. Ewen S, Lobo MD, Pathak A, Schmieder RE, Tsioufis C, Wijns W, Mahfoud F. Will SPRINT change my practice? SPRINT: a randomised trial of intensive versus standard blood-pressure control.
    EuroIntervention 2016;12(6):809-12.
  19. Donazzan L, Mahfoud F, Ewen S, Ukena C, Cremers B, Kirsch CM, Hellwig D, Eweiwi T, Ezziddin S, Esler M, Böhm M. Effects of catheter-based renal denervation on cardiac sympathetic activity and innervation in patients with resistant hypertension.
    Clin Res Cardiol 2016;105(4):364-71.
  20. De Jager RL, Sanders MF, Bots ML, Lobo MD, Ewen S, Beeftink MM, Böhm M, Daemen J, Dorr O, Hering D, Mahfoud F, Nef H, Ott C, Saxena M, Schmieder RE, Schlaich MP, Spiering W, Tonino PA, Verloop WL, Vink EE, Vonken EJ, Voskuil M, Worthley SG, Blankestijn PJ. Renal denervation in hypertensivepatients not on blood pressure lowering drugs.
    Clin Res Cardiol 2016;105(9):755-62.
  21. Böhm M, Ukena C, Ewen S, Linz D, Zivanovic I, Hoppe U, Narkiewicz K, Ruilope L, Schlaich M, Negoita M, Schmieder R, Williams B, Zeymer U, Zirlik A, Mancia G, Mahfoud F. Renal denervation reduces office and ambulatory heart rate in patients with uncontrolled hypertension: 12-month outcomes from the global SYMPLICITY registry.
    J Hypertens 2016;34(12):2480-2486.
  22. Böhm M, Robertson M, Borer J, Ford I, Komajda M, Mahfoud F, Ewen S, Swedberg K, Tavazzi L. Effect of Visit-to-Visit Variation of Heart Rate and Systolic Blood Pressure on Outcomes in Chronic Systolic Heart Failure: Results From the Systolic Heart Failure Treatment With the If Inhibitor Ivabradine Trial (SHIFT) Trial.
    J Am Heart Assoc 2016;5(2).
  23. Böhm M, Lloyd SM, Ford I, Borer JS, Ewen S, Laufs U, Mahfoud F, Lopez-Sendon J, Ponikowski P, Tavazzi L, Swedberg K, Komajda M. Non-adherence to ivabradine and placebo and outcomes in chronic heart failure: an analysis from SHIFT.
    Eur J Heart Fail 2016;18(6):672-83.
Jahrgang 2015
  1. Mahfoud F, Tunev S, Ewen S, Cremers B, Ruwart J, Schulz-Jander D, Linz D, Davies J, Kandzari DE, Whitbourn R, Böhm M, Melder RJ. Impact of Lesion Placement on Efficacy and Safety of Catheter-Based Radiofrequency Renal Denervation.
    J Am Coll Cardiol 2015;66(16):1766-75.
  2. Ewen S, Dorr O, Ukena C, Linz D, Cremers B, Laufs U, Hamm C, Nef H, Bauer A, Mancia G, Böhm M, Mahfoud F. Blood pressure variability after catheter-based renal sympathetic denervation in patients with resistant hypertension.
    J Hypertens 2015;33(12):2512-8.
  3. Ewen S, Cremers B, Meyer MR, Donazzan L, Kindermann I, Ukena C, Helfer AG, Maurer HH, Laufs U, Grassi G, Böhm M, Mahfoud F. Blood pressure changes after catheter-based renal denervation are related to reductions in total peripheral resistance.
    J Hypertens 2015;33(12):2519-25.
  4. Bramlage P, Schmieder RE, Gitt AK, Baumgart P, Mahfoud F, Buhck H, Ouarrak T, Ehmen M, Potthoff SA. The renin-angiotensin receptor blocker azilsartan medoxomil compared with the angiotensin-converting enzyme inhibitor ramipril in clinical trials versus routine practice: insights from the prospective EARLY registry. Trials 2015;16:581.
  5. Howard JP, Patel H, Shun-Shin MJ, Mourad JJ, Blacher J, Mahfoud F, Zeller T, Weber M, Francis DP. Impact of number of prescribed medications on visit-to-visit variability of blood pressure: implications for design of future trials of renal denervation.
    J Hypertens 2015;33(11):2359-67.
  6. Ewen S, Meyer MR, Cremers B, Laufs U, Helfer AG, Linz D, Kindermann I, Ukena C, Burnier M, Wagenpfeil S, Maurer HH, Böhm M, Mahfoud F.
    Blood pressure reductions following catheter-based renal denervation are not related to improvements in adherence to antihypertensive drugs measured by urine/plasma toxicological analysis.
    Clin Res Cardiol 2015;104(12):1097-105
  7. Mahfoud F, Böhm M, Azizi M, Pathak A, Durand Zaleski I, Ewen S, Tsioufis K, Andersson B, Blankestijn PJ, Burnier M, Chatellier G, Gafoor S, Grassi G, Joner M, Kjeldsen SE, Luscher TF, Lobo MD, Lotan C, Parati G, Redon J, Ruilope L, Sudano I, Ukena C, van Leeuwen E, Volpe M, Windecker S, Witkowski A, Wijns W, Zeller T, Schmieder RE.
    Proceedings from the European clinical consensus conference for renal denervation: considerations on future clinical trial design.
    Eur Heart J 2015;36(33):2219-27.
  8. Zannad F, Stough WG, Mahfoud F, Bakris GL, Kjeldsen SE, Kieval RS, Haller H, Yared N, De Ferrari GM, Pina IL, Stein K, Azizi M.
    Design considerations for clinical trials of autonomic modulation therapies targeting hypertension and heart failure.
    Hypertension 2015;65(1):5-15.
  9. Ewen S, Mahfoud F, Böhm M.
    Chronic heart failure: current guideline recommendations and innovations.
    Internist (Berl) 2015;56(7):791-802.
  10. Vonend O, Böhm M, Eckert S, Hausberg M, Rittger H, Rump LC, Schmieder R, Schulte KL, Schunkert H, Uder M, Veelken R, Vorwerk D, Weil J, Wenzel U, Mahfoud F.
    Renal denervation in refractory hypertension: joint statement of the German hypertension league DHL eV and the German societies of cardiology, angiology, nephrology and radiology.
    Dtsch Med Wochenschr 2015;140(5):363.
  11. Tzafriri AR, Keating JH, Markham PM, Spognardi AM, Stanley JR, Wong G, Zani BG, Highsmith D, O'Fallon P, Fuimaono K, Mahfoud F, Edelman ER.
    Arterial microanatomy determines the success of energy-based renal denervation in controlling hypertension.
    Sci Transl Med 2015;7(285):285ra65.
  12. Schmieder RE, Potthoff SA, Bramlage P, Baumgart P, Mahfoud F, Buhck H, Ouarrak T, Ehmen M, Senges J, Gitt AK.
    Patients with newly diagnosed hypertension treated with the renin angiotensin receptor blocker azilsartan medoxomil vs angiotensin-converting enzyme inhibitors: The prospective EARLY registry.
    J Clin Hypertens (Greenwich) 2015. (published online).
  13. Schirmer SH, Sayed MM, Reil JC, Lavall D, Ukena C, Linz D, Mahfoud F, Böhm M.
    Atrial Remodeling Following Catheter-Based Renal Denervation Occurs in a Blood Pressure- and Heart Rate-Independent Manner.
    JACC Cardiovasc Interv 2015;8(7):972-80.
  14. Pöss J, Ukena C, Kindermann I, Ehrlich P, Fuernau G, Ewen S, Mahfoud F, Kriechbaum S, Böhm M, Link A.
    Angiopoietin-2 and outcome in patients with acute decompensated heart failure.
    Clin Res Cardiol 2015;104(5):380-7.
  15. Pöss J, Ewen S, Schmieder RE, Muhler S, Vonend O, Ott C, Linz D, Geisel J, Rump LC, Schlaich M, Böhm M, Mahfoud F.
    Effects of renal sympathetic denervation on urinary sodium excretion in patients with resistant hypertension.
    Clin Res Cardiol 2015;104(8):672-8.
  16. Pathak A, Coleman L, Roth A, Stanley J, Bailey L, Markham P, Ewen S, Morel C, Despas F, Honton B, Senard JM, Fajadet J, Mahfoud F.
    Renal sympathetic nerve denervation using intraluminal ultrasound within a cooling balloon preserves the arterial wall and reduces sympathetic nerve activity.
    EuroIntervention 2015;11(4):477-84.
  17. Ott C, Mahfoud F, Schmid A, Toennes SW, Ewen S, Ditting T, Veelken R, Ukena C, Uder M, Böhm M, Schmieder RE.
    Renal denervation preserves renal function in patients with chronic kidney disease and resistant hypertension.
    J Hypertens 2015;33(6):1261-6.
  18. Mahfoud F, Serruys PW.
    Renal denervation reloaded: where to go from here?
    EuroIntervention 2015;10(10):1135-7.
  19. Mahfoud F, Ruilope LM, Böhm M, Schmieder RE.
    Aldosterone antagonists and renal denervation: friends or foes?
    Hypertension 2015;65(2):280-2.
  20. Mahfoud F, Lüscher TF.
    Renal denervation: symply trapped by complexity?
    Eur Heart J 2015;36(4):199-202.
  21. Mahfoud F, Böhm M.
    Hypertension: Arteriovenous anastomosis--next panacea for hypertension?
    Nat Rev Cardiol 2015;12(4):197-8.
  22. Linz D, van Hunnik A, Hohl M, Mahfoud F, Wolf M, Neuberger HR, Casadei B, Reilly SN, Verheule S, Böhm M, Schotten U.
    Catheter-based renal denervation reduces atrial nerve sprouting and complexity of atrial fibrillation in goats.
    Circ Arrhythm Electrophysiol 2015;8(2):466-74.
  23. Linz D, Hohl M, Ukena C, Mahfoud F, Wirth K, Neuberger HR, Böhm M.
    Obstructive respiratory events and premature atrial contractions after cardioversion.
    Eur Respir J 2015;45(5):1332-40.
  24. Linz D, Hohl M, Schutze J, Mahfoud F, Speer T, Linz B, Hubschle T, Juretschke HP, Dechend R, Geisel J, Rutten H, Böhm M.
    Progression of kidney injury and cardiac remodeling in obese spontaneously hypertensive rats: the role of renal sympathetic innervation.
    Am J Hypertens 2015;28(2):256-65.
  25. Linicus Y, Kindermann I, Helfer AG, Meyer MR, Maurer HH, Mahfoud F, Böhm M.
    Witnessed drug intake before planned denervation--always harmless?
    Int J Cardiol 2015;179:125-6.
  26. Kintscher U, Mahfoud F.
    Therapy of hypertension--2015.
    Dtsch Med Wochenschr 2015;140(11):835-42; quiz 843-4.
  27. Kim BK, Böhm M, Mahfoud F, Mancia G, Park S, Hong MK, Kim HS, Park SJ, Park CG, Seung KB, Gwon HC, Choi DJ, Ahn TH, Kim CJ, Kwon HM, Esler M, Jang YS.
    Renal denervation for treatment of uncontrolled hypertension in an Asian population: results from the Global SYMPLICITY Registry in South Korea (GSR Korea).
    J Hum Hypertens 2015. (published online)
  28. Ewen S, Ukena C, Linz D, Kindermann I, Cremers B, Laufs U, Wagenpfeil S, Schmieder RE, Böhm M, Mahfoud F.
    Reduced effect of percutaneous renal denervation on blood pressure in patients with isolated systolic hypertension.
    Hypertension 2015;65(1):193-9.
  29. Ewen S, Mahfoud F, Böhm M.
    Chronic heart failure: current guideline recommendations and innovations.
    Internist (Berl) 2015;56(7):791-802.
  30. Ewen S, Linicus Y, Böhm M. Update on therapy of chronic heart failure: Innovations and studies from last year.
    Herz 2015.
  31. Ewen S, Böhm M.
    Too much is too much: evidence against dual RAAS inhibition in hypertensives with heart failure symptoms.
    Eur Heart J 2015;36(15):899-901.
  32. Ewen S, Baumgarten T, Rettig-Ewen V, Mahfoud F, Griese-Mammen N, Schulz M, Böhm M, Laufs U.
    Analyses of drugs stored at home by elderly patients with chronic heart failure.
    Clin Res Cardiol 2015;104(4):320-7.
  33. Dörr O, Liebetrau C, Mollmann H, Mahfoud F, Ewen S, Gaede L, Troidl C, Hoffmann J, Busch N, Laux G, Wiebe J, Bauer T, Hamm C, Nef H.
    Beneficial effects of renal sympathetic denervation on cardiovascular inflammation and remodeling in essential hypertension.
    Clin Res Cardiol 2015;104(2):175-84.
  34. Dörr O, Ewen S, Liebetrau C, Mollmann H, Gaede L, Linz D, Hohl M, Troidl C, Bauer T, Böhm M, Hamm C, Mahfoud F, Nef H.
    Neuropeptide Y as an indicator of successful alterations in sympathetic nervous activity after renal sympathetic denervation.
    Clin Res Cardiol 2015. (published online)
  35. Donazzan L, Mahfoud F, Schirmer SH, Böhm M. Renal nerve ablation. Heart 2015;101(4):320-8.
  36. Böhm M, Schumacher H, Schmieder RE, Mann JF, Teo K, Lonn E, Sleight P, Mancia G, Linz D, Mahfoud F, Ukena C, Sliwa K, Bakris G, Yusuf S.
    Resting heart rate is associated with renal disease outcomes in patients with vascular disease: results of the ONTARGET and TRANSCEND studies.
    J Intern Med 2015;278(1):38-49.
  37. Böhm M, Mahfoud F, Ukena C, Hoppe UC, Narkiewicz K, Negoita M, Ruilope L, Schlaich MP, Schmieder RE, Whitbourn R, Williams B, Zeymer U, Zirlik A, Mancia G.
    First report of the Global SYMPLICITY Registry on the effect of renal artery denervation in patients with uncontrolled hypertension.
    Hypertension 2015;65(4):766-74.
  38. Armaganijan LV, Staico R, Moreira DA, Lopes RD, Medeiros PT, Habib R, Melo Neto J, Katz M, Armaganijan D, Sousa AG, Mahfoud F, Abizaid A.
    6-Month Outcomes in Patients With Implantable Cardioverter-Defibrillators Undergoing Renal Sympathetic Denervation for the Treatment of Refractory Ventricular Arrhythmias.
    JACC Cardiovasc Interv 2015;8(7):984-90.
Jahrgang 2014
  1. Ukena C, Mahfoud F, Böhm M.
    Cardiac diagnostic in hypertension.
    MMW Fortschr Med 2014;156(12):51-3.
  2. Ukena C, Kindermann M, Mahfoud F, Geisel J, Lepper PM, Kandolf R, Böhm M, Kindermann I.
    Diagnostic and prognostic validity of different biomarkers in patients with suspected myocarditis.
    Clin Res Cardiol 2014;103(9):743-51.
  3. Tzafriri AR, Mahfoud F, Keating JH, Markham PM, Spognardi A, Wong G, Fuimaono K, Böhm M, Edelman ER.
    Innervation patterns may limit response to endovascular renal denervation.
    J Am Coll Cardiol 2014;64(11):1079-87.
  4. Schwenger V, Remppis BA, Westenfeld R, Weinreich T, Brunkhorst R, Schieren G, Krumme B, Haller H, Schmieder R, Schlieper G, Frye B, Hoppe UC, Hoyer J, Keller T, Blumenstein M, Schunkert H, Mahfoud F, Rump LC.
    [Dialysis and ultrafiltration therapy in patients with cardio-renal syndrome: recommendations of the working group "heart-kidney" of the German Cardiac Society and the German Society of Nephrology].
    Dtsch Med Wochenschr 2014;139(7):e1-8.
  5. Pathak A, Ewen S, Fajadet J, Honton B, Mahfoud F, Marco J, Schlaich M, Schmieder R, Tsioufis K, Ukena C, Zeller T. From SYMPLICITY HTN-3 to the renal denervation global registry: where do we stand and where should we go?
    EuroIntervention 2014;10(1):21-3.
  6. Ott C, Mahfoud F, Schmid A, Ditting T, Veelken R, Ewen S, Ukena C, Uder M, Böhm M, Schmieder RE.
    Improvement of albuminuria after renal denervation.
    Int J Cardiol 2014;173(2):311-5.
  7. Mahfoud F, Urban D, Teller D, Linz D, Stawowy P, Hassel JH, Fries P, Dreysse S, Wellnhofer E, Schneider G, Buecker A, Schneeweis C, Doltra A, Schlaich MP, Esler MD, Fleck E, Böhm M, Kelle S.
    Effect of renal denervation on left ventricular mass and function in patients with resistant hypertension: data from a multi-centre cardiovascular magnetic resonance imaging trial.
    Eur Heart J 2014;35(33):2224-31b.
  8. Mahfoud F, Ukena C, Schmieder RE, Cremers B, Rump LC, Vonend O, Weil J, Schmidt M, Hoppe UC, Zeller T, Bauer A, Ott C, Blessing E, Sobotka PA, Krum H, Schlaich M, Esler M, Böhm M.
    Response to letter regarding article, "ambulatory blood pressure changes after renal sympathetic denervation in patients with resistant hypertension".
    Circulation 2014;129(20):e500-1.
  9. Mahfoud F, Tunev S, Ruwart J, Schulz-Jander D, Cremers B, Linz D, Zeller T, Bhatt DL, Rocha-Singh K, Böhm M, Melder RJ.
    Efficacy and safety of catheter-based radiofrequency renal denervation in stented renal arteries.
    Circ Cardiovasc Interv 2014;7(6):813-20.
  10. Mahfoud F, Linz D, Böhm M.
    Catheter-based renal denervation: treating hypertension or beyond?
    Chin Med J (Engl) 2014;127(6):1166-8.
  11. Mahfoud F, Edelman ER, Böhm M.
    Catheter-based renal denervation is no simple matter: lessons to be learned from our anatomy?
    J Am Coll Cardiol 2014;64(7):644-6.
  12. Mahfoud F.
    Renal sympathetic denervation: still to follow after Symplicity HTN-3? Yes.
    Dtsch Med Wochenschr 2014;139(48):2466.
  13. Luscher TF, Mahfoud F.
    Renal nerve ablation after SYMPLICITY HTN-3: confused at the higher level?
    Eur Heart J 2014;35(26):1706-11.
  14. Linz D, van Hunnik A, Ukena C, Ewen S, Mahfoud F, Schirmer SH, Lenski M, Neuberger HR, Schotten U, Böhm M.
    Renal denervation: effects on atrial electrophysiology and arrhythmias.
    Clin Res Cardiol 2014;103(10):765-74.
  15. Linz D, Ukena C, Esler M, Böhm M, Mahfoud F.
    Response to letter regarding article, "renal denervation for the treatment of cardiovascular high risk-hypertension or beyond?".
    Circ Res 2014;115(7):e19-20.
  16. Linz D, Mahfoud F, Linz B, Hohl M, Schirmer SH, Wirth KJ, Böhm M.
    Effect of obstructive respiratory events on blood pressure and renal perfusion in a pig model for sleep apnea.
    Am J Hypertens 2014;27(10):1293-300.
  17. Linz D, Hunnik A, Ukena C, Mahfoud F, Ewen S, Verheule S, Böhm M, Schotten U.
    Effects of renal denervation on atrial arrhythmogenesis.
    Future Cardiol 2014;10(6):813-22.
  18. Ewen S, Ukena C, Pöss J, Linz D, Böhm M, Mahfoud F.
    Interventional hypertension therapy in diabetes mellitus. Effects on blood pressure and glucose metabolism?.
    Herz 2014;39(3):325-30.
  19. Ewen S, Mahfoud F.
    EuroPCR 2014, Hypertension and Heart Failure Track take-home messages.
    Eur Heart J 2014;35(41):2850-1.
  20. Esler MD, Böhm M, Sievert H, Rump CL, Schmieder RE, Krum H, Mahfoud F, Schlaich MP.
    Catheter-based renal denervation for treatment of patients with treatment-resistant hypertension: 36 month results from the SYMPLICITY HTN-2 randomized clinical trial.
    Eur Heart J 2014;35(26):1752-9.
  21. Donazzan L, Mahfoud F, Linz D, Ewen S, Ukena C, Böhm M.
    Novel and nonpharmacologic approaches to cardio-protection in hypertension.
    Curr Hypertens Rep 2014;16(5):430.
  22. Böhm M, Mahfoud F.
    SYMPLICITY HTN-3 trial: what is it and what does it mean?
    Eur Heart J 2014;35(26):1697-8.
  23. Böhm M, Linz D, Ukena C, Esler M, Mahfoud F.
    Renal denervation for the treatment of cardiovascular high risk-hypertension or beyond?
    Circ Res 2014;115(3):400-9.
  24. Böhm M, Ewen S, Linz D, Reil JC, Schirmer S, Ukena C, Mahfoud F.
    Renal denervation: a novel non-pharmacological approach in heart failure.
    J Cardiovasc Transl Res 2014;7(3):330-7.
  25. Böhm M, Ewen S, Kindermann I, Linz D, Ukena C, Mahfoud F.
    Renal denervation and heart failure.
    Eur J Heart Fail 2014;16(6):608-13.
  26. Tsioufis C, Mahfoud F, Mancia G, Redon J, Damascelli B, Zeller T, Schmieder RE.
    What the interventionalist should know about renal denervation in hypertensive patients: A position paper by the esh wg on the interventional treatment of hypertension.
    EuroIntervention. 2014;9:1027-1035
  27. Schirmer SH, Sayed MM, Reil JC, Ukena C, Linz D, Kindermann M, Laufs U, Mahfoud F, Böhm M.
    Improvements in left ventricular hypertrophy and diastolic function following renal denervation: Effects beyond blood pressure and heart rate reduction.
    J Am Coll Cardiol. 2014;63:1916-1923
  28. Pöss J, Mahfoud F, Ukena C, Esler MD, Schlaich M, Hering D, Cremers B, Laufs U, Böhm M.
    Association of vitamin d status and blood pressure response after renal denervation.
    Clin Res Cardiol. 2014;103:41-47
  29. Pathak A, Ewen S, Fajadet J, Honton B, Mahfoud F, Marco J, Schlaich M, Schmieder R, Tsioufis K, Ukena C, Zeller T.
    From Symplicity HTN-3 to the renal denervation global registry: Where do we stand and where should we go?
    EuroIntervention. 2014;10:21-23
  30. Patel HC, Dhillon PS, Mahfoud F, Lindsay AC, Hayward C, Ernst S, Lyon AR, Rosen SD, di Mario C.
    The biophysics of renal sympathetic denervation using radiofrequency energy.
    Clin Res Cardiol. 2014;103:337-344
  31. Ott C, Mahfoud F, Schmid A, Ditting T, Veelken R, Ewen S, Ukena C, Uder M, Böhm M, Schmieder RE.
    Improvement of albuminuria after renal denervation.
    Int J Cardiol. 2014;173:311-315
  32. Mahfoud F, Urban D, Teller D, Linz D, Stawowy P, Hassel JH, Fries P, Dreysse S, Wellnhofer E, Schneider G, Buecker A, Schneeweis C, Doltra A, Schlaich MP, Esler MD, Fleck E, Böhm M, Kelle S.
    Effect of renal denervation on left ventricular mass and function in patients with resistant hypertension: Data from a multi-centre cardiovascular magnetic resonance imaging trial.
    Eur Heart J. 2014
  33. Ewen S, Mahfoud F, Linz D, Pöss J, Cremers B, Kindermann I, Laufs U, Ukena C, Böhm M.
    Effects of renal sympathetic denervation on exercise blood pressure, heart rate, and capacity in patients with resistant hypertension.
    Hypertension. 2014;63:839-845
  34. Mahfoud F, Ukena C, Schmieder RE, Cremers B, Rump LC, Vonend O, Weil J, Schmidt M, Hoppe UC, Zeller T, Bauer A, Ott C, Blessing E, Sobotka PA, Krum H, Schlaich M, Esler M, Böhm M.
    Response to letter regarding article, "ambulatory blood pressure changes after renal sympathetic denervation in patients with resistant hypertension".
    Circulation. 2014;129:e500-501
  35. Mahfoud F, Linz D, Böhm M.
    Catheter-based renal denervation: Treating hypertension or beyond?
    Chin Med J. 2014;127:1166-1168
  36. Lüscher TF, Mahfoud F.
    Renal nerve ablation after Symplicity HTN-3: Confused at the higher level?
    Eur Heart J. 2014;35:1706-1711
  37. Linz D, van Hunnik A, Ukena C, Ewen S, Mahfoud F, Schirmer SH, Lenski M, Neuberger HR, Schotten U, Böhm M.
    Renal denervation: Effects on atrial electrophysiology and arrhythmias.
    Clin Res Cardiol. 2014
  38. Linz D, Ukena C, Mahfoud F, Neuberger HR, Böhm M.
    Atrial autonomic innervation: A target for interventional antiarrhythmic therapy?
    J Am Coll Cardiol. 2014;63:215-224
  39. Linz D, Hohl M, Schutze J, Mahfoud F, Speer T, Linz B, Hubschle T, Juretschke HP, Dechend R, Geisel J, Rutten H, Böhm M.
    Progression of kidney injury and cardiac remodeling in obese spontaneously hypertensive rats: The role of renal sympathetic innervation.
    Am J Hypertens. 2014
  40. Krum H, Schlaich MP, Sobotka PA, Böhm M, Mahfoud F, Rocha-Singh K, Katholi R, Esler MD.
    Percutaneous renal denervation in patients with treatment-resistant hypertension: Final 3-year report of the Symplicity HTN-1 study.
    Lancet. 2014;383:622-629
  41. Ewen S, Ukena C, Pöss J, Linz D, Böhm M, Mahfoud F.
    Interventional hypertension therapy in diabetes mellitus. Effects on blood pressure and glucose metabolism?
    Herz. 2014;39:325-330
  42. Esler MD, Böhm M, Sievert H, Rump CL, Schmieder RE, Krum H, Mahfoud F, Schlaich MP.
    Catheter-based renal denervation for treatment of patients with treatment-resistant hypertension: 36 month results from the Symplicity HTN-2 randomized clinical trial.
    Eur Heart J. 2014;35:1752-1759
  43. Donazzan L, Mahfoud F, Linz D, Ewen S, Ukena C, Böhm M.
    Novel and nonpharmacologic approaches to cardio-protection in hypertension.
    Curr Hypertens Rep. 2014;16:430
  44. Böhm M, Linz D, Ukena C, Esler M, Mahfoud F.
    Renal denervation for the treatment of cardiovascular high risk-hypertension or beyond?
    Circ Res. 2014;115:400-409
  45. Böhm M, Ewen S, Linz D, Reil JC, Schirmer S, Ukena C, Mahfoud F.
    Renal denervation: A novel non-pharmacological approach in heart failure.
    J Cardiovasc Transl Res. 2014;7:330-337
  46. Böhm M, Ewen S, Kindermann I, Linz D, Ukena C, Mahfoud F.
    Renal denervation and heart failure.
    Eur J Heart Fail. 2014;16:608-613
Jahrgang 2013
  1. Urban D, Ewen S, Ukena C, Linz D, Böhm M, Mahfoud F.
    Treating resistant hypertension: Role of renal denervation.
    Integr Blood Press Control. 2013;6:119-128
  2. Ukena C, Mahfoud F, Spies A, Kindermann I, Linz D, Cremers B, Laufs U, Neuberger HR, Böhm M.
    Effects of renal sympathetic denervation on heart rate and atrioventricular conduction in patients with resistant hypertension.
    Int J Cardiol. 2013;167:2846-2851
  3. Ukena C, Mahfoud F, Linz D, Böhm M, Neuberger HR.
    Potential role of renal sympathetic denervation for the treatment of cardiac arrhythmias.
    EuroIntervention. 2013;9 Suppl R:R110-116
  4. Ukena C, Mahfoud F, Ewen S, Cremers B, Laufs U, Böhm M.
    Renal denervation in the treatment of hypertension.
    Curr Hypertens Rep. 2013;15:363-369
  5. Ukena C, Cremers B, Ewen S, Böhm M, Mahfoud F.
    Response and non-response to renal denervation: Who is the ideal candidate?
    EuroIntervention. 2013;9 Suppl R:R54-57
  6. Thoenes M, Spirk D, Böhm M, Mahfoud F, Thevathasan L, Bramlage P.
    Treatment of hypertension in the elderly: Data from an international cohort of hypertensives treated by cardiologists.
    J Hum Hypertens. 2013;27:131-137
  7. Sudano I, Mahfoud F.
    Renal nerve ablation for treatment of therapy-resistant hypertension.
    Eur Heart J. 2013;34:865-868
  8. Schmieder RE, Ruilope LM, Ott C, Mahfoud F, Böhm M.
    Interpreting treatment-induced blood pressure reductions measured by ambulatory blood pressure monitoring.
    J Hum Hypertens. 2013;27:715-720
  9. Schlaich MP, Schmieder RE, Bakris G, Blankestijn PJ, Böhm M, Campese VM, Francis DP, Grassi G, Hering D, Katholi R, Kjeldsen S, Krum H, Mahfoud F, Mancia G, Messerli FH, Narkiewicz K, Parati G, Rocha-Singh KJ, Ruilope LM, Rump LC, Sica DA, Sobotka PA, Tsioufis C, Vonend O, Weber MA, Williams B, Zeller T, Esler MD.
    International expert consensus statement: Percutaneous transluminal renal denervation for the treatment of resistant hypertension.
    J Am Coll Cardiol. 2013;62:2031-2045
  10. Schlaich MP, Bart B, Hering D, Walton A, Marusic P, Mahfoud F, Böhm M, Lambert EA, Krum H, Sobotka PA, Schmieder RE, Ika-Sari C, Eikelis N, Straznicky N, Lambert GW, Esler MD.
    Feasibility of catheter-based renal nerve ablation and effects on sympathetic nerve activity and blood pressure in patients with end-stage renal disease.
    Int J Cardiol. 2013;168:2214-2220
  11. Ott C, Mahfoud F, Schmid A, Ditting T, Sobotka PA, Veelken R, Spies A, Ukena C, Laufs U, Uder M, Böhm M, Schmieder RE.
    Renal denervation in moderate treatment-resistant hypertension.
    J Am Coll Cardiol. 2013;62:1880-1886
  12. Mahfoud F, Ukena C, Schmieder RE, Cremers B, Rump LC, Vonend O, Weil J, Schmidt M, Hoppe UC, Zeller T, Bauer A, Ott C, Blessing E, Sobotka PA, Krum H, Schlaich M, Esler M, Böhm M.
    Ambulatory blood pressure changes after renal sympathetic denervation in patients with resistant hypertension.
    Circulation. 2013;128:132-140
  13. Mahfoud F, Luscher TF, Andersson B, Baumgartner I, Cifkova R, Dimario C, Doevendans P, Fagard R, Fajadet J, Komajda M, Lefevre T, Lotan C, Sievert H, Volpe M, Widimsky P, Wijns W, Williams B, Windecker S, Witkowski A, Zeller T, Böhm M.
    Expert consensus document from the european society of cardiology on catheter-based renal denervation.
    Eur Heart J. 2013;34:2149-2157
  14. Mahfoud F, Kjeldsen SE.
    Catheter-based renal denervation: A word of caution.
    EuroIntervention. 2013;8
  15. Mahfoud F, Ewen S, Ukena C, Linz D, Sobotka PA, Cremers B, Böhm M.
    Expanding the indication spectrum: Renal denervation in diabetes.
    EuroIntervention. 2013;9 Suppl R:R117-121
  16. Mahfoud F, Böhm M, Rump LC, Vonend O, Schmieder RE, Kintscher U.
    Catheter-based renal nerve ablation and centrally generated sympathetic activity in difficult-to-control hypertensive patients: Prospective case series.
    Hypertension. 2013;61:e17
  17. Mahfoud F, Bhatt DL.
    Catheter-based renal denervation: The black box procedure.
    JACC Cardiovasc Interv. 2013;6:1092-1094
  18. Luscher TF, de Feyter P, Sabate M, Van Mieghem NM, Mahfoud F, Serruys PW.
    The european heart journal and eurointervention: Information and education in interventional cardiology.
    EuroIntervention. 2013;9:669-680
  19. Linz D, Wirth K, Ukena C, Mahfoud F, Pöss J, Linz B, Böhm M, Neuberger HR.
    Renal denervation suppresses ventricular arrhythmias during acute ventricular ischemia in pigs.
    Heart Rhythm. 2013;10:1525-1530
  20. Linz D, Mahfoud F, Schotten U, Ukena C, Neuberger HR, Wirth K, Böhm M.
    Effects of electrical stimulation of carotid baroreflex and renal denervation on atrial electrophysiology.
    J Cardiovasc Electrophysiol. 2013;24:1028-1033
  21. Linz D, Mahfoud F, Schotten U, Ukena C, Hohl M, Neuberger HR, Wirth K, Böhm M.
    Renal sympathetic denervation provides ventricular rate control but does not prevent atrial electrical remodeling during atrial fibrillation.
    Hypertension. 2013;61:225-231
  22. Linz D, Hohl M, Nickel A, Mahfoud F, Wagner M, Ewen S, Schotten U, Maack C, Wirth K, Böhm M.
    Effect of renal denervation on neurohumoral activation triggering atrial fibrillation in obstructive sleep apnea.
    Hypertension. 2013;62:767-774
  23. Lenski M, Mahfoud F, Razouk A, Ukena C, Lenski D, Barth C, Linz D, Laufs U, Kindermann I, Böhm M.
    Orthostatic function after renal sympathetic denervation in patients with resistant hypertension.
    Int J Cardiol. 2013;169:418-424
  24. Lenski D, Kindermann I, Lenski M, Ukena C, Bunz M, Mahfoud F, Böhm M.
    Anxiety, depression, quality of life and stress in patients with resistant hypertension before and after catheter-based renal sympathetic denervation.
    EuroIntervention. 2013;9:700-708
  25. Kjeldsen SE, Os I, Mahfoud F.
    Treatment resistant hypertension and renal sympathetic denervation: Drug adherence and the consolidation of blood pressure lowering effects.
    EuroIntervention. 2013;9 Suppl R:R7-9
  26. Hering D, Lambert EA, Marusic P, Ika-Sari C, Walton AS, Krum H, Sobotka PA, Mahfoud F, Böhm M, Lambert GW, Esler MD, Schlaich MP.
    Renal nerve ablation reduces augmentation index in patients with resistant hypertension.
    J Hypertens. 2013;31:1893-1900
  27. Gitt AK, Baumgart P, Bramlage P, Mahfoud F, Potthoff SA, Senges J, Schneider S, Buhck H, Schmieder RE.
    Early treatment with azilsartan compared to ace-inhibitors in anti-hypertensive therapy--rationale and design of the early hypertension registry.
    BMC Cardiovasc Disord. 2013;13:46
  28. Ewen S, Ukena C, Linz D, Schmieder RE, Böhm M, Mahfoud F.
    The sympathetic nervous system in chronic kidney disease.
    Curr Hypertens Rep. 2013;15:370-376
  29. Ewen S, Ukena C, Böhm M, Mahfoud F.
    Percutaneous renal denervation: New treatment option for resistant hypertension and more?
    Heart. 2013;99:1129-1134
  30. Ewen S, Mahfoud F, Böhm M.
    First-in-human experience: Percutaneous renal denervation through a false lumen fenestration in aortic dissection type b.
    EuroIntervention. 2013;8:1110
  31. Daemen J, Mahfoud F.
    Renal denervation: Expanding the indication.
    EuroIntervention. 2013;9 Suppl R:R101-104
  32. Böhm M, Mahfoud F, Ukena C, Bauer A, Fleck E, Hoppe UC, Kintscher U, Narkiewicz K, Negoita M, Ruilope L, Rump LC, Schlaich M, Schmieder R, Sievert H, Weil J, Williams B, Zeymer U, Mancia G.
    Rationale and design of a large registry on renal denervation: The Global Symplicity Registry.
    EuroIntervention. 2013;9:484-492
  33. Böhm M, Linz D, Urban D, Mahfoud F, Ukena C.
    Renal sympathetic denervation: Applications in hypertension and beyond.
    Nat Rev Cardiol. 2013;10:465-476
  34. Böhm M, Ewen S, Linz D, Reil JC, Schirmer SH, Ukena C, Mahfoud F.
    Therapeutic potential of renal sympathetic denervation in patients with chronic heart failure.
    EuroIntervention. 2013;9 Suppl R:R122-126
Jahrgang 2012
  1. Ukena C, Dobre D, Mahfoud F, Kindermann I, Lamiral Z, Tala S, Rossignol P, Turgonyi E, Pitt B, Böhm M, Zannad F.
    Hypo- and hyperglycemia predict outcome in patients with left ventricular dysfunction after acute myocardial infarction: Data from ephesus.
    J Card Fail. 2012;18:439-445
  2. Ukena C, Bauer A, Mahfoud F, Schreieck J, Neuberger HR, Eick C, Sobotka PA, Gawaz M, Böhm M.
    Renal sympathetic denervation for treatment of electrical storm: First-in-man experience.
    Clin Res Cardiol. 2012;101:63-67
  3. Pöss J, Ukena C, Mahfoud F, Gensch C, Werner C, Thoenes M, Bramlage P, Volpe M, Laufs U, Böhm M.
    Physical activity is inversely associated with microalbuminuria in hypertensive patients at high cardiovascular risk: Data from i-search.
    Eur J Prev Cardiol. 2012;19:1066-1073
  4. Mahfoud F, Ukena C, Pöss J, Bramlage P, Volpe M, Thoenes M, Schmieder R, Böhm M.
    Microalbuminuria independently correlates to cardiovascular comorbidity burden in patients with hypertension.
    Clin Res Cardiol. 2012;101:761-766
  5. Mahfoud F, Ukena C, Kandolf R, Kindermann M, Böhm M, Kindermann I.
    Blood pressure and heart rate predict outcome in patients acutely admitted with suspected myocarditis without previous heart failure.
    J Hypertens. 2012;30:1217-1224
  6. Mahfoud F, Noory E, Böhm M, Zeller T.
    Revascularization of renal artery stenosis--state of the art.
    vDtsch Med Wochenschr. 2012;137:2505-2510
  7. Mahfoud F, Cremers B, Janker J, Link B, Vonend O, Ukena C, Linz D, Schmieder R, Rump LC, Kindermann I, Sobotka PA, Krum H, Scheller B, Schlaich M, Laufs U, Böhm M.
    Renal hemodynamics and renal function after catheter-based renal sympathetic denervation in patients with resistant hypertension.
    Hypertension. 2012;60:419-424
  8. Mahfoud F, Böhm M, Baumhakel M.
    Inadequate reporting of concomitant drug treatment in cardiovascular interventional head-to-head trials.
    Clin Cardiol. 2012;35:255-256
  9. Linz D, Mahfoud F, Schotten U, Ukena C, Neuberger HR, Wirth K, Böhm M.
    Renal sympathetic denervation suppresses postapneic blood pressure rises and atrial fibrillation in a model for sleep apnea.
    Hypertension. 2012;60:172-178
  10. Linz D, Hohl M, Mahfoud F, Reil JC, Linz W, Hubschle T, Juretschke HP, Neumann-Haflin C, Rutten H, Böhm M.
    Cardiac remodeling and myocardial dysfunction in obese spontaneously hypertensive rats.
    J Transl Med. 2012;10:187
  11. Brandt MC, Reda S, Mahfoud F, Lenski M, Böhm M, Hoppe UC.
    Effects of renal sympathetic denervation on arterial stiffness and central hemodynamics in patients with resistant hypertension.
    J Am Coll Cardiol. 2012;60:1956-1965
  12. Brandt MC, Mahfoud F, Reda S, Schirmer SH, Erdmann E, Böhm M, Hoppe UC.
    Renal sympathetic denervation reduces left ventricular hypertrophy and improves cardiac function in patients with resistant hypertension.
    J Am Coll Cardiol. 2012;59:901-909
Jahrgang 2011
  1. Ukena C, Mahfoud F, Kindermann I, Barth C, Lenski M, Kindermann M, Brandt MC, Hoppe UC, Krum H, Esler M, Sobotka PA, Böhm M.
    Cardiorespiratory response to exercise after renal sympathetic denervation in patients with resistant hypertension.
    J Am Coll Cardiol. 2011;58:1176-1182
  2. Sobotka PA, Mahfoud F, Schlaich MP, Hoppe UC, Böhm M, Krum H.
    Sympatho-renal axis in chronic disease.
    Clin Res Cardiol. 2011;100:1049-1057
  3. Schlaich MP, Straznicky N, Grima M, Ika-Sari C, Dawood T, Mahfoud F, Lambert E, Chopra R, Socratous F, Hennebry S, Eikelis N, Böhm M, Krum H, Lambert G, Esler MD, Sobotka PA.
    Renal denervation: A potential new treatment modality for polycystic ovary syndrome?
    J Hypertens. 2011;29:991-996
  4. Mahfoud F, Vonend O, Bruck H, Clasen W, Eckert S, Frye B, Haller H, Hausberg M, Hoppe UC, Hoyer J, Hahn K, Keller T, Kramer BK, Kreutz R, Potthoff SA, Reinecke H, Schmieder R, Schwenger V, Kintscher U, Böhm M, Rump LC.
    Expert consensus statement on interventional renal sympathetic denervation for hypertension treatment.
    Dtsch Med Wochenschr. 2011;136:2418
  5. Mahfoud F, Schlaich M, Kindermann I, Ukena C, Cremers B, Brandt MC, Hoppe UC, Vonend O, Rump LC, Sobotka PA, Krum H, Esler M, Böhm M.
    Effect of renal sympathetic denervation on glucose metabolism in patients with resistant hypertension: A pilot study.
    Circulation. 2011;123:1940-1946
  6. Mahfoud F, Lenski M, Böhm M.
    Is there a role for renal sympathetic denervation in the future treatment of resistant hypertension?
    Future Cardiol. 2011;7:591-594
  7. Mahfoud F, Himmel F, Ukena C, Schunkert H, Böhm M, Weil J.
    Treatment strategies for resistant arterial hypertension.
    Dtsch Arztebl Int. 2011;108:725-731
  8. Krum H, Sobotka P, Mahfoud F, Böhm M, Esler M, Schlaich M.
    Device-based antihypertensive therapy: Therapeutic modulation of the autonomic nervous system.
    Circulation. 2011;123:209-215
  9. Hering D, Esler MD, Krum H, Mahfoud F, Böhm M, Sobotka PA, Schlaich MP.
    Recent advances in the treatment of hypertension.
    Expert Rev Cardiovasc Ther. 2011;9:729-744
  10. Catheter-based renal sympathetic denervation for resistant hypertension: Durability of blood pressure reduction out to 24 months.
    Hypertension. 2011;57:911-917
Jahrgang 2010
  1. Esler MD, Krum H, Sobotka PA, Schlaich MP, Schmieder RE, Böhm M.
    Renal sympathetic denervation in patients with treatment-resistant hypertension (the Symplicity HTN-2 trial): A randomised controlled trial.
    Lancet. 2010;376:1903-1909
  2. Böhm M, Baumhakel M, Mahfoud F, Werner C.
    From evidence to rationale: Cardiovascular protection by angiotensin ii receptor blockers compared with angiotensin-converting enzyme inhibitors.
    Cardiology. 2010;117:163-173